
Innovation Fund
Advancing diagnostic medicine by investing in the ideas and innovations of our experts, developing a creative and forward-looking culture to help us to transform pathology.
Advancing diagnostic medicine by investing in the ideas and innovations of our experts, developing a creative and forward-looking culture to help us to transform pathology.
The Innovation Fund helps our people to get their ideas from the drawing board to practical application, making a tangible difference to our patients and customers by improving the service we provide.
A brief history
The Innovation Fund was established in November 2013 to ensure that good ideas are getting the funding they need to get off the ground and have a positive impact on our service.
We recognise that improvements in diagnostic medicine will only come about as the result of innovative projects and research which will define the quality and delivery of patient care in the future.
The Fund has been a great success since its launch, leading Viapath to double the amount of money individuals can bid for to support their projects from 2015. Our scientific experts are full of bright, innovative ideas, and Viapath will continue to support them in bringing these ideas to life.
Over £160,000 in funding has been awarded to over 30 projects. Some of the projects have led to the introduction of new tests to our repertoire which have added a valuable revenue stream, allowing us to continue our significant investment programme. The window for applications opens twice each year for more ideas and projects, we truly are committed to a culture of innovation to help us to transform pathology.
Outcomes and achievements
Find links below to articles, papers and posters published as part of an Innovation Fund project.
Click below to view the poster Dr David Taylor from Clinical Biochemistry at King's, presented at EuroLabFocus in October 2014. This innovation funded project explores the use of Liquid Chromotography Mass Spectrometry to simultaneously quantify multiple steroids in serum.
Click below to view the poster Simon Handley from Clinical Biochemistry at King's presented at EuroLabFocus in October 2014. This project which was granted innovation funding investigates the viability of mass spectrometric immunoassay for the quantification of hepcidin-25 and its isoforms, which may be useful in the differential diagnosis of iron deficient anaemia.
Some of the latest innovations funded by Viapath are shared at our Innovation Academy events. To listen to recordings of presentations and to read abstracts and author bios visit our events page HERE.
Last updated: 28/08/2015